Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 30:11:567955.
doi: 10.3389/fendo.2020.567955. eCollection 2020.

Fetuin-A in Infants Born Small- or Large-for-Gestational-Age

Affiliations

Fetuin-A in Infants Born Small- or Large-for-Gestational-Age

Wen-Juan Wang et al. Front Endocrinol (Lausanne). .

Abstract

Fetuin-A is a multifunctional glycoprotein that has been implicated in insulin resistance and bone metabolism. We assessed whether fetuin-A is associated with poor or excessive fetal growth. In the Shanghai Birth Cohort, we conducted a nested case-control study of 60 trios of small-for-gestational-age (SGA, birth weight <10th percentile), optimal-for-gestational-age (OGA, 25-75th, the reference) and large-for-gestational-age (LGA, >90th percentile) infants matched by sex and gestational age. Cord plasma concentrations of fetuin-A and fetal growth factors [insulin, proinsulin, insulin-like growth factor (IGF)-I and IGF-II] were measured. Cord plasma fetuin-A concentrations were higher in SGA (809.4 ± 306.9 μg/ml, P = 0.026) and LGA (924.2 ± 375.9 μg/ml, P < 0.001) relative to OGA (680.7 ± 262.1 μg/ml) newborns, and were not correlated to insulin, proinsulin, IGF-I and IGF-II (all P > 0.2). Higher fetuin-A concentrations were associated with increased risks of SGA [OR = 1.67 (1.08-2.58) per SD increment, P = 0.024] and LGA [OR = 2.36 (1.53-3.66), P < 0.001]. Adjusting for maternal and neonatal characteristics and fetal growth factors, the elevated risk changed little for LGA [adjusted OR = 2.28 (1.29-4.01), P = 0.005], but became non-significant for SGA (P = 0.202). Our study is the first to demonstrate that fetuin-A may be involved in excessive fetal growth. This association is independent of fetal growth factors.

Keywords: fetuin A; insulin; insulin-like growth factor; large-for-gestational-age; small-for-gestational-age.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart in the selection of study subjects in a nested matched case control study of SGA, LGA, and OGA newborns in the Shanghai Birth Cohort. SGA, small-for-gestational-age (birth weight <10th percentile); LGA, large-for-gestational-age (>90th percentile); OGA, optimal-for-gestational-age (25–75th percentiles).
Figure 2
Figure 2
Cord plasma fetuin-A concentrations in small-, optimal-, or large-for-gestational-age (SGA, OGA, LGA) infants. The boxes represent the medians and interquartile ranges, the dots represent the maximal values. P = 0.024 comparing SGA vs. OGA, and P < 0.001 comparing LGA vs. OGA.

References

    1. Pal D, Dasgupta S, Kundu R, Maitra S, Das G, Mukhopadhyay S, et al. . Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med. (2012) 18:1279–85. 10.1038/nm.2851 - DOI - PubMed
    1. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Krober SM, et al. . Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care. (2006) 29:853–7. 10.2337/diacare.29.04.06.dc05-1938 - DOI - PubMed
    1. Mathews ST, Singh GP, Ranalletta M, Cintron VJ, Qiang X, Goustin AS, et al. . Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes. (2002) 51:2450–8. 10.2337/diabetes.51.8.2450 - DOI - PubMed
    1. Shim YS Kang MJ Oh YJ Baek JW Yang S Hwang IT . Fetuin-A as an alternative marker for insulin resistance and cardiovascular risk in prepubertal children. J Atheroscler Thromb. (2017) 24:1031–8. 10.5551/jat.38323 - DOI - PMC - PubMed
    1. Mathews ST, Chellam N, Srinivas PR, Cintron VJ, Leon MA, Goustin AS, et al. . Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol. (2000) 164:87–98. 10.1016/S0303-7207(00)00237-9 - DOI - PubMed

Publication types

Grants and funding